Skip to main content
Top
Published in: Digestive Diseases and Sciences 11/2010

01-11-2010 | Original Article

Psychosocial Factors Are More Important Than Disease Activity in Determining Gastrointestinal Symptoms and Health Status in Adults at a Celiac Disease Referral Center

Authors: Spencer D. Dorn, Lincoln Hernandez, Maria T. Minaya, Carolyn B. Morris, Yuming Hu, Suzanne Lewis, Jane Leserman, Shrikant I. Bangdiwala, Peter H. R. Green, Douglas A. Drossman

Published in: Digestive Diseases and Sciences | Issue 11/2010

Login to get access

Abstract

Background

The relative effects of clinical and psychosocial variables on outcome in celiac disease (CD) has not previously been reported. In adult patients with (CD), we studied the relationships among demographics, psychosocial factors, and disease activity with health-related quality of life (HRQOL), health care utilization, and symptoms.

Methods

Among 101 adults newly referred to a tertiary care center with biopsy-proven CD we assessed: (a) demographic factors and diet status; (b) disease measures (Marsh score, tissue transglutaminase antibody (tTG) level, weight change and additional blood studies); and (c) Psychosocial status (psychological distress, life stress, abuse history, and coping). Multivariate analyses were performed to predict HRQOL, daily function, self-reported health, number of physician visits, and GI symptoms (pain and diarrhea).

Results

Impaired HRQOL and daily function was associated with psychological distress and poorer coping. Self-report of poorer health was associated with poorer coping, longer symptom duration, lower education, and greater weight loss. More physician visits were associated with poorer coping, abnormal tTG levels, and milder Marsh classification. Greater pain scores were seen in those with higher psychological distress and greater weight loss. Finally, diarrhea was associated with greater psychological distress and poorer coping.

Conclusions

In patients presenting to a CD referral center, psychosocial factors more strongly affect health status and GI symptoms than disease measures.
Literature
1.
go back to reference James SP. National Institutes of Health consensus development conference statement on celiac disease, June 28–30, 2004. Gastroenterology. 2005;128:S1–S9.CrossRef James SP. National Institutes of Health consensus development conference statement on celiac disease, June 28–30, 2004. Gastroenterology. 2005;128:S1–S9.CrossRef
2.
go back to reference Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterology. 1992;102:330–354.PubMed Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterology. 1992;102:330–354.PubMed
3.
go back to reference Green PHR. The many faces of celiac disease: clinical presentation of celiac disease in the adult population. Gastroenterology. 2005;128:S74–S78.CrossRefPubMed Green PHR. The many faces of celiac disease: clinical presentation of celiac disease in the adult population. Gastroenterology. 2005;128:S74–S78.CrossRefPubMed
4.
go back to reference Brar P, Kwon GY, Egbuna II, et al. Lack of correlation of degree of villous atrophy with severity of clinical presentation of coeliac disease. Dig Liver Dis. 2007;39:26–29.CrossRefPubMed Brar P, Kwon GY, Egbuna II, et al. Lack of correlation of degree of villous atrophy with severity of clinical presentation of coeliac disease. Dig Liver Dis. 2007;39:26–29.CrossRefPubMed
6.
go back to reference Drossman DA, Patrick DL, Mitchell CM, Zagami EA, Appelbaum MI. Health related quality of life in inflammatory bowel disease: functional status and patient worries and concerns. Dig Dis Sci. 1989;34:1379–1386.CrossRefPubMed Drossman DA, Patrick DL, Mitchell CM, Zagami EA, Appelbaum MI. Health related quality of life in inflammatory bowel disease: functional status and patient worries and concerns. Dig Dis Sci. 1989;34:1379–1386.CrossRefPubMed
7.
go back to reference Levy RL, Olden KW, Naliboff BD, et al. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology. 2006;130:1447–1458.CrossRefPubMed Levy RL, Olden KW, Naliboff BD, et al. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology. 2006;130:1447–1458.CrossRefPubMed
8.
go back to reference Drossman DA. Presidential address: gastrointestinal illness and biopsychosocial model. Psychosom Med. 1998;60:258–267.PubMed Drossman DA. Presidential address: gastrointestinal illness and biopsychosocial model. Psychosom Med. 1998;60:258–267.PubMed
9.
go back to reference Drossman DA, Toner BB, Whitehead WE, et al. Cognitive-behavioral therapy verses education and desipramine verses placebo for moderate to severe functional bowel disorders. Gastroenterology. 2003;125:19–31.CrossRefPubMed Drossman DA, Toner BB, Whitehead WE, et al. Cognitive-behavioral therapy verses education and desipramine verses placebo for moderate to severe functional bowel disorders. Gastroenterology. 2003;125:19–31.CrossRefPubMed
10.
go back to reference Donaldson MR, Firth SD, Wimpee H, et al. Correlation of duodenal histology with tissue transglutaminase and endomysial antibody levels in pediatric celiac disease. Clin Gastroenterol Hepatol. 2007;5:567–573.CrossRefPubMed Donaldson MR, Firth SD, Wimpee H, et al. Correlation of duodenal histology with tissue transglutaminase and endomysial antibody levels in pediatric celiac disease. Clin Gastroenterol Hepatol. 2007;5:567–573.CrossRefPubMed
11.
go back to reference Tursi A, Brandimarte G, Giorgetti GM. Prevalence of antitissue transglutaminase antibodies in different degrees of intestinal damage in celiac disease. J Clin Gastroenterol. 2003;36:219–221.CrossRefPubMed Tursi A, Brandimarte G, Giorgetti GM. Prevalence of antitissue transglutaminase antibodies in different degrees of intestinal damage in celiac disease. J Clin Gastroenterol. 2003;36:219–221.CrossRefPubMed
12.
go back to reference Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32:920–924.CrossRefPubMed Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32:920–924.CrossRefPubMed
13.
go back to reference Derogatis LR. SCL-90-R: Administration, Scoring, and Procedures Manual II—For the R(evised) Version. Towson: Clinical Psychometric Research; 1983. Derogatis LR. SCL-90-R: Administration, Scoring, and Procedures Manual II—For the R(evised) Version. Towson: Clinical Psychometric Research; 1983.
14.
go back to reference Kroenke K. Studying symptoms: sampling and measurement issues. Ann Intern Med. 2001;134(2):844–853.PubMed Kroenke K. Studying symptoms: sampling and measurement issues. Ann Intern Med. 2001;134(2):844–853.PubMed
15.
go back to reference Rosenstiel AK, Keefe FJ. The use of coping strategies in chronic low back pain patients: relationship to patient characteristics and current adjustment. Pain. 1983;17:33–44.CrossRefPubMed Rosenstiel AK, Keefe FJ. The use of coping strategies in chronic low back pain patients: relationship to patient characteristics and current adjustment. Pain. 1983;17:33–44.CrossRefPubMed
16.
go back to reference Sarason IG, Johnson JH, Siegel JM. Assessing the impact of life changes: development of the life experiences survey. J Consult Clin Psychol. 1978;46:932–946.CrossRefPubMed Sarason IG, Johnson JH, Siegel JM. Assessing the impact of life changes: development of the life experiences survey. J Consult Clin Psychol. 1978;46:932–946.CrossRefPubMed
17.
go back to reference Leserman J, Li Z, Drossman DA, Toomey TC, Nachman G, Glogau L. Impact of sexual and physical abuse dimensions on health status: development of an abuse severity measure. Psychosom Med. 1997;59:152–160.PubMed Leserman J, Li Z, Drossman DA, Toomey TC, Nachman G, Glogau L. Impact of sexual and physical abuse dimensions on health status: development of an abuse severity measure. Psychosom Med. 1997;59:152–160.PubMed
18.
go back to reference Bergner M, Bobbitt RA, Carter WB. The sickness impact profile: development and final revision of a health status measure. Med Care. 1981;19:787–805.CrossRefPubMed Bergner M, Bobbitt RA, Carter WB. The sickness impact profile: development and final revision of a health status measure. Med Care. 1981;19:787–805.CrossRefPubMed
19.
go back to reference Drossman D, Morris CB, Hu Y, et al. Characterization of health related quality of life (HRQOL) for patients with functional bowel disorder (FBD) and its response to treatment. Am J Gastroenterol. 2007;102:1442–1453.CrossRefPubMed Drossman D, Morris CB, Hu Y, et al. Characterization of health related quality of life (HRQOL) for patients with functional bowel disorder (FBD) and its response to treatment. Am J Gastroenterol. 2007;102:1442–1453.CrossRefPubMed
20.
go back to reference Drossman DA, Patrick DL, Whitehead WE, et al. Further validation of the IBS-QOL: a disease specific quality of life questionnaire. Am J Gastoenterol. 2000;95:999–1007.CrossRef Drossman DA, Patrick DL, Whitehead WE, et al. Further validation of the IBS-QOL: a disease specific quality of life questionnaire. Am J Gastoenterol. 2000;95:999–1007.CrossRef
21.
go back to reference Drossman DA, Toner BB, Whitehead WE, Diamant NE, Dalton CB, Emmott S, Proffitt V, Akman D, Frusciante K, Meyer K, Blackman C, Hu Y, Jia H, Li Z, Morris CB, Koch GG, Bangdiwala S. A multi-center randomized trial of cognitive-behavioral treatment (cbt) vs. education (edu) in moderate to severe functional bowel disorder (fbd). 124 ed. A-530; 2003. Drossman DA, Toner BB, Whitehead WE, Diamant NE, Dalton CB, Emmott S, Proffitt V, Akman D, Frusciante K, Meyer K, Blackman C, Hu Y, Jia H, Li Z, Morris CB, Koch GG, Bangdiwala S. A multi-center randomized trial of cognitive-behavioral treatment (cbt) vs. education (edu) in moderate to severe functional bowel disorder (fbd). 124 ed. A-530; 2003.
22.
go back to reference Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. In: Drossman DA, Corazziari E, Delvaux M, Spiller RC, Talley NJ, Thompson WG, Whitehead WE, eds. Rome III: The Functional Gastrointestinal Disorders. 3rd ed. McLean, VA: Degnon Associates, Inc.; 2006:487–555. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. In: Drossman DA, Corazziari E, Delvaux M, Spiller RC, Talley NJ, Thompson WG, Whitehead WE, eds. Rome III: The Functional Gastrointestinal Disorders. 3rd ed. McLean, VA: Degnon Associates, Inc.; 2006:487–555.
23.
go back to reference Eisenberg L. Disease and illness. Distinctions between professional and popular ideas of sickness. Cult Med Psychiatry. 1977;1:9–23.CrossRefPubMed Eisenberg L. Disease and illness. Distinctions between professional and popular ideas of sickness. Cult Med Psychiatry. 1977;1:9–23.CrossRefPubMed
24.
go back to reference Engel GL. The need for a new medical model: a challenge for biomedicine. Science. 1977;196:129–136.CrossRefPubMed Engel GL. The need for a new medical model: a challenge for biomedicine. Science. 1977;196:129–136.CrossRefPubMed
25.
go back to reference Murray JA, Rubio-Tapia A, Van Dyke CT, et al. Mucosal atrophy in celiac disease: extent of involvement, correlation with clinical presentation, and response to treatment. Clin Gastroenterol Hepatol. 2008;6:186–193.CrossRefPubMed Murray JA, Rubio-Tapia A, Van Dyke CT, et al. Mucosal atrophy in celiac disease: extent of involvement, correlation with clinical presentation, and response to treatment. Clin Gastroenterol Hepatol. 2008;6:186–193.CrossRefPubMed
26.
go back to reference Lo W, Sano K, Lebwohl B, Diamond B, Green PH. Changing presentation of adult celiac disease. Dig Dis Sci. 2003;48:395–398.CrossRefPubMed Lo W, Sano K, Lebwohl B, Diamond B, Green PH. Changing presentation of adult celiac disease. Dig Dis Sci. 2003;48:395–398.CrossRefPubMed
27.
go back to reference Rampertab SD, Pooran N, Brar P, Singh P, Green PH. Trends in the presentation of celiac disease. Am J Med. 2006;119:355.e14.CrossRef Rampertab SD, Pooran N, Brar P, Singh P, Green PH. Trends in the presentation of celiac disease. Am J Med. 2006;119:355.e14.CrossRef
28.
go back to reference Leffler DA, Dennis M, Hyett B, Kelly E, Schuppan D, Kelly CP. Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol. 2007;5:445–450.CrossRefPubMed Leffler DA, Dennis M, Hyett B, Kelly E, Schuppan D, Kelly CP. Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol. 2007;5:445–450.CrossRefPubMed
29.
go back to reference Coleman NS, Foley S, Dunlop SP, et al. Abnormalities of serotonin metabolism and their relation to symptoms in untreated celiac disease. Clin Gastroenterol Hepatol. 2006;4:874–881.CrossRefPubMed Coleman NS, Foley S, Dunlop SP, et al. Abnormalities of serotonin metabolism and their relation to symptoms in untreated celiac disease. Clin Gastroenterol Hepatol. 2006;4:874–881.CrossRefPubMed
30.
go back to reference Gwee KA, Graham JC, McKendrick MW, et al. Psychometric scores and persistence of irritable bowel after infectious diarrhoea [see comments]. Lancet. 1996;347:150–153.CrossRefPubMed Gwee KA, Graham JC, McKendrick MW, et al. Psychometric scores and persistence of irritable bowel after infectious diarrhoea [see comments]. Lancet. 1996;347:150–153.CrossRefPubMed
31.
go back to reference Simren M, Axelsson J, Gillberg R, Abrahamsson H, Svedlund J, Bjornsson ES. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol. 2002;97:389–396.PubMed Simren M, Axelsson J, Gillberg R, Abrahamsson H, Svedlund J, Bjornsson ES. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol. 2002;97:389–396.PubMed
32.
go back to reference Hauser W, Musial F, Caspary WF, Stein J, Stallmach A. Predictors of irritable bowel-type symptoms and healthcare-seeking behavior among adults with celiac disease. Psychosom Med. 2007;69:370–376.CrossRefPubMed Hauser W, Musial F, Caspary WF, Stein J, Stallmach A. Predictors of irritable bowel-type symptoms and healthcare-seeking behavior among adults with celiac disease. Psychosom Med. 2007;69:370–376.CrossRefPubMed
33.
go back to reference O’Leary C, Wieneke P, Buckley S, et al. Celiac disease and irritable bowel-type symptoms. Am J Gastroenterol. 2002;97:1463–1467.CrossRefPubMed O’Leary C, Wieneke P, Buckley S, et al. Celiac disease and irritable bowel-type symptoms. Am J Gastroenterol. 2002;97:1463–1467.CrossRefPubMed
34.
go back to reference Usai P, Manca R, Cuomo R, Lai MA, Boi MF. Effect of gluten-free diet and co-morbidity of irritable bowel syndrome-type symptoms on health-related quality of life in adult coeliac patients. Dig Liver Dis. 2007;39:824–828.CrossRefPubMed Usai P, Manca R, Cuomo R, Lai MA, Boi MF. Effect of gluten-free diet and co-morbidity of irritable bowel syndrome-type symptoms on health-related quality of life in adult coeliac patients. Dig Liver Dis. 2007;39:824–828.CrossRefPubMed
35.
go back to reference Fera T, Cascio B, Angelini G, Martini S, Guidetti CS. Affective disorders and quality of life in adult coeliac disease patients on a gluten-free diet. Eur J Gastroenterol Hepatol. 2003;15:1287–1292.CrossRefPubMed Fera T, Cascio B, Angelini G, Martini S, Guidetti CS. Affective disorders and quality of life in adult coeliac disease patients on a gluten-free diet. Eur J Gastroenterol Hepatol. 2003;15:1287–1292.CrossRefPubMed
36.
go back to reference Addolorato G, Leggio L, D’Angelo C, et al. Affective and psychiatric disorders in celiac disease. Dig Dis. 2008;26:140–148.CrossRefPubMed Addolorato G, Leggio L, D’Angelo C, et al. Affective and psychiatric disorders in celiac disease. Dig Dis. 2008;26:140–148.CrossRefPubMed
37.
go back to reference Ciacci C, D’Agate C, De Rosa A, et al. Self-rated quality of life in celiac disease. Dig Dis Sci. 2003;48:2216–2220.CrossRefPubMed Ciacci C, D’Agate C, De Rosa A, et al. Self-rated quality of life in celiac disease. Dig Dis Sci. 2003;48:2216–2220.CrossRefPubMed
38.
go back to reference de Rosa A, Troncone A, Vacca M, Ciacci C. Characteristics and quality of illness behavior in celiac disease. Psychosomatics. 2004;45:336–342.CrossRefPubMed de Rosa A, Troncone A, Vacca M, Ciacci C. Characteristics and quality of illness behavior in celiac disease. Psychosomatics. 2004;45:336–342.CrossRefPubMed
39.
go back to reference Drossman DA. A biopsychosocial understanding of gastrointestinal illness and disease. In: Feldman M, Scharschmidt B, Sleisenger MH, eds. Sleisenger and Fordtrans’s Gastrointestinal Disease. 7th ed. Philadelphia: W.B. Saunders; 2002:2373–2385. Drossman DA. A biopsychosocial understanding of gastrointestinal illness and disease. In: Feldman M, Scharschmidt B, Sleisenger MH, eds. Sleisenger and Fordtrans’s Gastrointestinal Disease. 7th ed. Philadelphia: W.B. Saunders; 2002:2373–2385.
40.
go back to reference Sullivan MJ, Thorn B, Haythornthwaite JA, et al. Theoretical perspectives on the relation between catastrophizing and pain. Clin J Pain. 2001;17:52–64.CrossRefPubMed Sullivan MJ, Thorn B, Haythornthwaite JA, et al. Theoretical perspectives on the relation between catastrophizing and pain. Clin J Pain. 2001;17:52–64.CrossRefPubMed
41.
go back to reference Drossman DA, Li Z, Leserman J, Keefe FJ, Hu YJ, Toomey TC. Effects of coping on health outcome among female patients with gastrointestinal disorders. Psychosom Med. 2000;62:309–317.PubMed Drossman DA, Li Z, Leserman J, Keefe FJ, Hu YJ, Toomey TC. Effects of coping on health outcome among female patients with gastrointestinal disorders. Psychosom Med. 2000;62:309–317.PubMed
42.
go back to reference Hallert C, Granno C, Hulten S, et al. Living with coeliac disease: controlled study of the burden of illness. Scand J Gastroenterol. 2002;37:39–42.CrossRefPubMed Hallert C, Granno C, Hulten S, et al. Living with coeliac disease: controlled study of the burden of illness. Scand J Gastroenterol. 2002;37:39–42.CrossRefPubMed
43.
go back to reference Hopper AD, Cross SS, Sanders DS. Patchy villous atrophy in adult patients with suspected gluten-sensitive enteropathy: is a multiple duodenal biopsy strategy appropriate? Endoscopy. 2008;40:219–224.CrossRefPubMed Hopper AD, Cross SS, Sanders DS. Patchy villous atrophy in adult patients with suspected gluten-sensitive enteropathy: is a multiple duodenal biopsy strategy appropriate? Endoscopy. 2008;40:219–224.CrossRefPubMed
44.
go back to reference Addolorato G, Stefanini GF, Capristo E, Caputo F, Gasbarrini A, Gasbarrini G. Anxiety and depression in adult untreated celiac subjects and in patients affected by inflammatory bowel disease: a personality “trait” or a reactive illness? Hepatogastroenterology. 1996;43:1513–1517.PubMed Addolorato G, Stefanini GF, Capristo E, Caputo F, Gasbarrini A, Gasbarrini G. Anxiety and depression in adult untreated celiac subjects and in patients affected by inflammatory bowel disease: a personality “trait” or a reactive illness? Hepatogastroenterology. 1996;43:1513–1517.PubMed
45.
go back to reference Addolorato G, Capristo E, Ghittoni G, et al. Anxiety but not depression decreases in coeliac patients after one-year gluten-free diet: a longitudinal study. Scand J Gastroenterol. 2001;36:502–506.CrossRefPubMed Addolorato G, Capristo E, Ghittoni G, et al. Anxiety but not depression decreases in coeliac patients after one-year gluten-free diet: a longitudinal study. Scand J Gastroenterol. 2001;36:502–506.CrossRefPubMed
46.
go back to reference Zarkadas M, Cranney A, Case S, et al. The impact of a gluten-free diet on adults with coeliac disease: results of a national survey. J Hum Nutr Diet. 2006;19:41–49.CrossRefPubMed Zarkadas M, Cranney A, Case S, et al. The impact of a gluten-free diet on adults with coeliac disease: results of a national survey. J Hum Nutr Diet. 2006;19:41–49.CrossRefPubMed
47.
go back to reference Grover M, Drossman DA. Psychotropic agents in functional gastrointestinal disorders. Curr Opin Pharmacol. 2008;8:715–723.CrossRefPubMed Grover M, Drossman DA. Psychotropic agents in functional gastrointestinal disorders. Curr Opin Pharmacol. 2008;8:715–723.CrossRefPubMed
Metadata
Title
Psychosocial Factors Are More Important Than Disease Activity in Determining Gastrointestinal Symptoms and Health Status in Adults at a Celiac Disease Referral Center
Authors
Spencer D. Dorn
Lincoln Hernandez
Maria T. Minaya
Carolyn B. Morris
Yuming Hu
Suzanne Lewis
Jane Leserman
Shrikant I. Bangdiwala
Peter H. R. Green
Douglas A. Drossman
Publication date
01-11-2010
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 11/2010
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-010-1342-y

Other articles of this Issue 11/2010

Digestive Diseases and Sciences 11/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.